Skip to main content
Dipenkumar Modi, MD, Hematology, Detroit, MI

DipenkumarKanaiyalalModiMD

Hematology Detroit, MI

Hematologic Oncology

Physician

Dr. Modi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Modi's full profile

Already have an account?

  • Office

    4100 John R St
    Detroit, MI 48201
    Phone+1 313-576-8780
    Fax+1 313-576-8661

Education & Training

  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2012 - 2015
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2015

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2012 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • HematologyHematology
  • Medical OncologyMedical Oncology

Awards, Honors, & Recognition

  • ASH Abstract Achievement Award American Society of Hematology, 2017

Publications & Presentations

PubMed

Journal Articles

  • Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.  
    Modi D, Ye JC, Surapaneni M, Singh V, Chen W, Jang H, Deol A, Ayash L, Alavi A, Ratanatharathorn V, Uberti JP, American Journal of Hematology, 7/10/2019

Abstracts/Posters

  • Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...
    Dipenkumar Modi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Grant to Barbara Ann Karmanos Cancer Institute Funds Study to Identify DLBCL Patients Likely to Relapse Post Autologous Stem Cell Transplantation
    Grant to Barbara Ann Karmanos Cancer Institute Funds Study to Identify DLBCL Patients Likely to Relapse Post Autologous Stem Cell TransplantationApril 6th, 2021
  • Karmanos Cancer Center Gets $320,000 Federal Grant for Lymphoma Research
    Karmanos Cancer Center Gets $320,000 Federal Grant for Lymphoma ResearchApril 5th, 2021
  • Karmanos Cancer Institute Receives a $325,372 Grant from U CAN-CER VIVE Foundation
    Karmanos Cancer Institute Receives a $325,372 Grant from U CAN-CER VIVE FoundationMarch 29th, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Gujarati